| | | | | | | | | | | | | | | | | | | | | |
<?xml version="1.0" encoding="windows-1252"?> |
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"> |
| <Version> 1.0.0.3 </Version> |
| <hasSegments> false </hasSegments> |
| <ReportName> Gain on sale of product rights </ReportName> |
| <RoundingOption/> |
| <Columns> |
| | <Column> |
| | | <LabelColumn> false </LabelColumn> |
| | | <Id> 1 </Id> |
| | | <Labels> |
| <Label Id="1" Label="12 Months Ended"/> |
| <Label Id="2" Label="Dec. 31, 2009"/> |
| <Label Id="3" Label="USD / shares"/> |
| </Labels> |
| | | <CurrencySymbol> $ </CurrencySymbol> |
| | | <hasSegments> false </hasSegments> |
| | | <hasScenarios> false </hasScenarios> |
| | | <Segments/> |
| | | <Scenarios/> |
| | | <Units> |
| <Unit> |
| <UnitID> EPS </UnitID> |
| <UnitType> Divide </UnitType> |
| <NumeratorMeasure> |
| <MeasureSchema> http://www.xbrl.org/2003/iso4217 </MeasureSchema> |
| <MeasureValue> USD </MeasureValue> |
| <MeasureNamespace> iso4217 </MeasureNamespace> |
| </NumeratorMeasure> |
| <DenominatorMeasure> |
| <MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema> |
| <MeasureValue> shares </MeasureValue> |
| <MeasureNamespace> xbrli </MeasureNamespace> |
| </DenominatorMeasure> |
| <Scale> 0 </Scale> |
| </Unit> |
| <Unit> |
| <UnitID> shares </UnitID> |
| <UnitType> Standard </UnitType> |
| <StandardMeasure> |
| <MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema> |
| <MeasureValue> shares </MeasureValue> |
| <MeasureNamespace> xbrli </MeasureNamespace> |
| </StandardMeasure> |
| <Scale> 0 </Scale> |
| </Unit> |
| <Unit> |
| <UnitID> USD </UnitID> |
| <UnitType> Standard </UnitType> |
| <StandardMeasure> |
| <MeasureSchema> http://www.xbrl.org/2003/iso4217 </MeasureSchema> |
| <MeasureValue> USD </MeasureValue> |
| <MeasureNamespace> iso4217 </MeasureNamespace> |
| </StandardMeasure> |
| <Scale> 0 </Scale> |
| </Unit> |
| </Units> |
| | | </Column> |
| | </Columns> |
| <Rows> |
| | <Row> |
| | | <Id> 2 </Id> |
| | | <Label> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </Label> |
| | | <Level> 0 </Level> |
| | | <ElementName> shpgf_NotesToTheConsolidatedFinancialStatementsAbstract </ElementName> |
| | | <ElementPrefix> shpgf </ElementPrefix> |
| | | <IsBaseElement> false </IsBaseElement> |
| | | <BalanceType> na </BalanceType> |
| | | <PeriodType> duration </PeriodType> |
| | | <ElementDataType> string </ElementDataType> |
| | | <ShortDefinition> No definition available. </ShortDefinition> |
| | | <IsReportTitle> false </IsReportTitle> |
| | | <IsSegmentTitle> false </IsSegmentTitle> |
| | | <IsSubReportEnd> false </IsSubReportEnd> |
| | | <IsCalendarTitle> false </IsCalendarTitle> |
| | | <IsTuple> false </IsTuple> |
| | | <IsAbstractGroupTitle> true </IsAbstractGroupTitle> |
| | | <IsBeginningBalance> false </IsBeginningBalance> |
| | | <IsEndingBalance> false </IsEndingBalance> |
| | | <IsEPS> false </IsEPS> |
| | | <Cells> |
| <Cell> |
| <Id> 1 </Id> |
| <ShowCurrencySymbol> false </ShowCurrencySymbol> |
| <IsNumeric> false </IsNumeric> |
| <NumericAmount> 0 </NumericAmount> |
| <RoundedNumericAmount> 0 </RoundedNumericAmount> |
| <NonNumbericText/> |
| <NonNumericTextHeader/> |
| <FootnoteIndexer/> |
| <hasSegments> false </hasSegments> |
| <hasScenarios> false </hasScenarios> |
| </Cell> |
| </Cells> |
| | | <ElementDefenition> No definition available. </ElementDefenition> |
| | | <IsTotalLabel> false </IsTotalLabel> |
| | | </Row> |
| | <Row> |
| | | <Id> 3 </Id> |
| | | <Label> Gain on sale of product rights (Disclosure) </Label> |
| | | <Level> 1 </Level> |
| | | <ElementName> shpgf_GainLossOnDispositionOfProductRightsTextBlock </ElementName> |
| | | <ElementPrefix> shpgf </ElementPrefix> |
| | | <IsBaseElement> false </IsBaseElement> |
| | | <BalanceType> na </BalanceType> |
| | | <PeriodType> duration </PeriodType> |
| | | <ElementDataType> string </ElementDataType> |
| | | <ShortDefinition> Disclosure of the facts and circumstances leading to the disposal of product rights and the gain or loss recognized in the... </ShortDefinition> |
| | | <IsReportTitle> false </IsReportTitle> |
| | | <IsSegmentTitle> false </IsSegmentTitle> |
| | | <IsSubReportEnd> false </IsSubReportEnd> |
| | | <IsCalendarTitle> false </IsCalendarTitle> |
| | | <IsTuple> false </IsTuple> |
| | | <IsAbstractGroupTitle> false </IsAbstractGroupTitle> |
| | | <IsBeginningBalance> false </IsBeginningBalance> |
| | | <IsEndingBalance> false </IsEndingBalance> |
| | | <IsEPS> false </IsEPS> |
| | | <Cells> |
| <Cell> |
| <Id> 1 </Id> |
| <ShowCurrencySymbol> false </ShowCurrencySymbol> |
| <IsNumeric> false </IsNumeric> |
| <NumericAmount> 0 </NumericAmount> |
| <RoundedNumericAmount> 0 </RoundedNumericAmount> |
| <NonNumbericText> <div style="font-size:12pt"><p>5. Gain on sale of product rights <br /><br />During 2007 and 2008 the Company streamlined its operations through the divestment of certain non-core products. In 2007 the Company received cash consideration of $234.4 million on the disposal of non core products, which included $209.6 million from Laboratorios Almirall S.A (“Almirall”) on the transfer of product licenses, including SOLARAZE and VANIQA, and in 2008 Shire received a further $5.0 million in cash for the transfer of other non-core product rights. <br /><br />The Company recognizes gains in respect of these divested product rights when the relevant regulatory or other consents for the transfer of these product rights are obtained. Accordingly Shire recognized gains of $6.3 million, $20.7 million and $127.8 million in the years to December 31, 2009, 2008 and 2007 respectively on disposal of these non-core assets. At December 31, 2009 the Company recorded as a deposit within Other current liabilities $5.8 million (2008: $12.5 million) of proceeds from the disposal of these products where regulatory or other consents have yet to be obtained.<br /><br />All assets disposed of during 2009, 2008 and 2007 formed part of the Specialty Pharmaceuticals segment.</p></div> </NonNumbericText> |
| <NonNumericTextHeader> 5. Gain on sale of product rights During 2007 and 2008 the Company streamlined its operations through the </NonNumericTextHeader> |
| <FootnoteIndexer/> |
| <hasSegments> false </hasSegments> |
| <hasScenarios> false </hasScenarios> |
| </Cell> |
| </Cells> |
| | | <ElementDefenition> Disclosure of the facts and circumstances leading to the disposal of product rights and the gain or loss recognized in the income statement </ElementDefenition> |
| | | <ElementReferences> No authoritative reference available. </ElementReferences> |
| | | <IsTotalLabel> false </IsTotalLabel> |
| | | </Row> |
| | </Rows> |
| <Footnotes/> |
| <ComparabilityReport> false </ComparabilityReport> |
| <NumberOfCols> 1 </NumberOfCols> |
| <NumberOfRows> 2 </NumberOfRows> |
| <HasScenarios> false </HasScenarios> |
| <MonetaryRoundingLevel> UnKnown </MonetaryRoundingLevel> |
| <SharesRoundingLevel> UnKnown </SharesRoundingLevel> |
| <PerShareRoundingLevel> UnKnown </PerShareRoundingLevel> |
| <HasPureData> false </HasPureData> |
| <SharesShouldBeRounded> true </SharesShouldBeRounded> |
| </InstanceReport> |